|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.24 HKD | +2.28% |
|
-3.03% | -10.04% |
Essex Bio-Technology Limited reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was HKD 899.36 million compared to HKD 655.83 million a year ago. Net income was HKD 169.81 million compared to HKD 139.23 million a year ago.
Basic earnings per share from continuing operations was HKD 0.2972 compared to HKD 0.2421 a year ago. Diluted earnings per share from continuing operations was HKD 0.288 compared to HKD 0.2352 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -10.04% | 159M | |
| -4.06% | 86.13B | |
| +1.97% | 39.82B | |
| +56.59% | 25.23B | |
| -14.82% | 15.36B | |
| -8.82% | 11.95B | |
| -16.29% | 11.6B | |
| -41.58% | 11.51B | |
| +6.14% | 8.71B | |
| -7.02% | 8.12B |
ESSEX BIO-TECHNOLOGY LIMITED 
